Endocrine and metabolic adaptations to pregnancy; impact of obesity

References

1. Hytten FE. Water storage in pregnancy. Midwife Health Visit 1967;3:60–2.Search in Google Scholar

2. Larciprete G, Valensise H, Vasapollo B, Altomare F, Sorge R, Casalino B, De Lorenzo A, Arduini D. Body composition during normal pregnancy: reference ranges. Acta Diabetol 2003;40:S225–32.10.1007/s00592-003-0072-4Search in Google Scholar

3. King JC, Butte NF, Bronstein MN, Kopp LE, Lindquist SA. Energy metabolism during pregnancy: influence of maternal energy status. Am J Clin Nutr 1994;59:439S–45S.10.1093/ajcn/59.2.439SSearch in Google Scholar

4. Poppitt SD, Prentice AM, Goldberg GR, Whitehead RG. Energy-sparing strategies to protect human fetal growth. Am J Obstet Gynecol 1994;171:118–25.10.1016/S0002-9378(94)70087-7Search in Google Scholar

5. Resi V, Basu S, Haghiac M, Presley L, Minium J, Kaufman B, Bernard S, Catalano P, Hauguel-de Mouzon S. Molecular inflammation and adipose tissue matrix remodeling precede physiological adaptations to pregnancy. Am J Physiol Endocrinol Metab 2012;303:E832–40.10.1152/ajpendo.00002.2012Search in Google Scholar

6. Herrera E, Amusquivar E. Lipid metabolism in the fetus and the newborn. Diabetes Metab Res Rev 2000;16:202–10.10.1002/1520-7560(200005/06)16:3<202::AID-DMRR116>3.0.CO;2-#Search in Google Scholar

7. Meyer BJ, Stewart FM, Brown EA, Cooney J, Nilsson S, Olivecrona G, Ramsay JE, Griffin BA, Caslake MJ, Freeman DJ. Maternal obesity is associated with the formation of small dense LDL and hypoadiponectinemia in the third trimester. J Clin Endocrinol Metab 2013;98:643–52.10.1210/jc.2012-3481Search in Google Scholar

8. Potter JM, Nestel PJ. Hyperlipidemia of pregnancy in normal and complicated pregnancies. Am J Obstet Gynecol 1979;133:165–70.10.1016/0002-9378(79)90469-1Search in Google Scholar

9. Herrera E. Metabolic adaptations in pregnancy and their implications for the availability of substrates to the fetus. Eur J Clin Nutr 2000;54(Suppl 1):S47–51.10.1038/sj.ejcn.1600984Search in Google Scholar

10. Kim HJ, Kalkhoff RK. Sex steroid influence on triglyceride metabolism. J Clin Invest 1975;56:888–96.10.1172/JCI108168Search in Google Scholar

11. Highman TJ, Friedman JE, Huston LP, Wong WW, Catalano PM. Longitudinal changes in maternal serum leptin concentrations, body composition, and resting metabolic rate in pregnancy. Am J Obstet Gynecol 1998;178:1010–5.10.1016/S0002-9378(98)70540-XSearch in Google Scholar

12. Lepercq J, Cauzac M, Lahlou N, Timsit J, Girard J, Auwerx, Hauguel-de Mouzon S. Overexpression of placental leptin in diabetic pregnancy: a critical role for insulin. Diabetes 1998;47:847–50.10.2337/diabetes.47.5.847Search in Google Scholar PubMed

13. Hauguel-de Mouzon S, Lepercq J, Catalano P. The known and unknown of leptin in pregnancy. Am J Obstet Gynecol 2006;194:1537–45.10.1016/j.ajog.2005.06.064Search in Google Scholar PubMed

14. Considine R, Sinha M, Heiman M. Serum immunoreactive leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292–5.10.1056/NEJM199602013340503Search in Google Scholar PubMed

15. Fruhbeck G, Jebb SA, Prentice AM. Leptin: physiology and pathophysiology. Clin Physiol 1998;18:399–419.10.1046/j.1365-2281.1998.00129.xSearch in Google Scholar PubMed

16. Catalano PM, Hoegh M, Minium J, Huston-Presley L, Bernard S, Kalhan S, Hauguel-de Mouzon S. Adiponectin in human pregnancy: implications for regulation of glucose and lipid metabolism. Diabetologia 2006;49:1677–85.10.1007/s00125-006-0264-xSearch in Google Scholar PubMed

17. Haghiac M, Basu S, Presley L, Serre D, Catalano PM, Hauguel-de Mouzon S. Patterns of adiponectin expression in term pregnancy; impact of obesity. J Clin Endorinol Metab 2014;99:3427–34.10.1210/jc.2013-4074Search in Google Scholar PubMed PubMed Central

18. Rosario FJ, Schumacher MA, Jiang J, Kanai Y, Powell TL, Jansson T. Chronic maternal infusion of full-length adiponectin in pregnant mice down-regulates placental amino acid transporter activity and expression and decreases fetal growth. J Physiol 2012;590(Pt 6):1495–509.10.1113/jphysiol.2011.226399Search in Google Scholar PubMed PubMed Central

19. Kallen CB. Steroid hormone synthesis in pregnancy. Obstet Gynecol Clin North Am 2004;31:795–816.10.1016/j.ogc.2004.08.009Search in Google Scholar PubMed

20. Pepe G, Albrecht E. Steroid endocrinology of pregnancy. In: Knobil, E, editor. Glob libr. Women’s Med., 2008. ISSN: 1756-2228.10.3843/GLOWM.10311Search in Google Scholar

21. Lassance L, Haghiac M, Minium J, Catalano P, Hauguel-de Mouzon S. Obesity-induced down-regulation of the mitochondrial translocator protein (TSPO) impairs placental steroid production. J Clin Endocrinol Metab 2015;100:E11–8.10.1210/jc.2014-2792Search in Google Scholar PubMed PubMed Central

22. Moog-Lutz C. Tomasetto C, Régnier CH, Wendling C, Lutz Y, Muller D, Chenard MP, Basset P, Rio MC. MLN64 exhibits homology with the steroidogenic acute regulatory protein (STAR) and is over-expressed in human breast carcinomas. Int J Cancer 1997;71:183–191.10.1002/(SICI)1097-0215(19970410)71:2<183::AID-IJC10>3.0.CO;2-JSearch in Google Scholar

23. Fan J, Lindemann P, Feuilloley MG, Papadopoulos V. Structural and functional evolution of the translocator protein (18 kDa). Curr Mol Med 2012;12:369–86.10.2174/1566524011207040369Search in Google Scholar

24. Chernick S, Novak M. Effect of insulin on FFA mobilization and ketosis in fasting pregnant rats. Diabetes 1970;19:563–70.10.2337/diab.19.8.563Search in Google Scholar

25. Perley M, Kipnis DM. Effect of glucocorticoids on plasma insulin. N Engl J Med 1966;274:1237–41.10.1056/NEJM196606022742205Search in Google Scholar

26. Metzger BE, Ravnikar V, Vileisis RA, Freinkel N. Accelerated starvation and the skipped breakfast in late normal pregnancy. Lancet 1982;i:588–92.10.1016/S0140-6736(82)91750-0Search in Google Scholar

27. Catalano PM, Drago NM, Amini SB. Longitudinal changes in pancreatic beta-cell function and metabolic clearance rate of insulin in pregnant women with normal and abnormal glucose tolerance. Diabetes Care 1998;21:403–8.10.2337/diacare.21.3.403Search in Google Scholar

28. Ryan EA, O’Sullivan MJ, Skyler JS. Insulin action during pregnancy studies with the euglycemic clamp technique. Diabetes 1985;34:380–9.10.2337/diab.34.4.380Search in Google Scholar

29. Berson SA, Yalow RS. Insulin “antagonists” and insulin resistance. In: Ellenberg M, Rifkin H, editors. Diabetes mellitus: theory and practice, New York: McGraw-Hill, 1970:388–423.Search in Google Scholar

30. Spellacy WN, Goetz FC. Plasma insulin in normal late pregnancy. N Engl J Med 1963;268:988–91.10.1056/NEJM196305022681805Search in Google Scholar

31. Turner RC, Harris E, Ounsted M, Ponsford C. Two abnormalities of glucose-induced insulin secretion: dose-response characteristics and insulin sensitivity. Acta Endocrinol (Copenh) 1979;92:148–65.10.1530/acta.0.0920148Search in Google Scholar

32. Buchanan TA, Metzger BE, Freinkel N, Bergman RN. Insulin sensitivity and B-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes. Am J Obstet Gynecol 1990;162:1008–14.10.1016/0002-9378(90)91306-WSearch in Google Scholar

33. Catalano PM, Hauguel-De Mouzon S. Is it time to revisit the Pedersen hypothesis in the face of the obesity epidemic? Am J Obstet Gynecol 2011;204:479–87.10.1016/j.ajog.2010.11.039Search in Google Scholar

34. Hauguel-de Mouzon S, Guerre-Millo M. The placenta cytokine network and inflammatory signals. Placenta 2006;27:794–8.10.1016/j.placenta.2005.08.009Search in Google Scholar

35. Kirwan JP, Hauguel-De Mouzon S, Lepercq J, Challier JC, Huston-Presley L, Friedman JE, Kalhan SC, Catalano PM. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes 2002;51:2207–13.10.2337/diabetes.51.7.2207Search in Google Scholar

36. Kim JK. Fat uses a TOLL-road to connect inflammation and diabetes. Cell Metab 2006;4:417–9.10.1016/j.cmet.2006.11.008Search in Google Scholar

37. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier J. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006;116:3015–25.10.1172/JCI28898Search in Google Scholar

38. Tsukumo DM, Carvalho-Filho MA, Carvalheira JB, Prada PO, Hirabara SM, Schenka AA, Araújo EP, Vassallo J, Curi R, Velloso LA, Saad JA. Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 2007;56:1986–98.10.2337/db06-1595Search in Google Scholar

39. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, Mullany EC, Biryukov S, Abbafati C, Abera SF, Abraham JP, Abu-Rmeileh NM, Achoki T, AlBuhairan FS, Alemu ZA, Alfonso R, Ali MK, Ali R, Guzman NA, Ammar W, Anwari P, Banerjee A, Barquera S, Basu S, Bennett DA, Bhutta Z, Blore J, Cabral N, Nonato IC, Chang JC, Chowdhury R, Courville KJ, Criqui MH, Cundiff DK, Dabhadkar KC, Dandona L, Davis A, Dayama A, Dharmaratne SD, Ding EL, Durrani AM, Esteghamati A, Farzadfar F, Fay DF, Feigin VL, Flaxman A, Forouzanfar MH, Goto A, Green MA, Gupta R, Hafezi-Nejad N, Hankey GJ, Harewood HC, Havmoeller R, Hay S, Hernandez L, Husseini A, Idrisov BT, Ikeda N, Islami F, Jahangir E, Jassal SK, Jee SH, Jeffreys M, Jonas JB, Kabagambe EK, Khalifa SE, Kengne AP, Khader YS, Khang YH, Kim D, Kimokoti RW, Kinge JM, Kokubo Y, Kosen S, Kwan G, Lai T, Leinsalu M, Li Y, Liang X, Liu S, Logroscino G, Lotufo PA, Lu Y, Ma J, Mainoo NK, Mensah GA, Merriman TR, Mokdad AH, Moschandreas J, Naghavi M, Naheed A, Nand D, Narayan KM, Nelson EL, Neuhouser ML, Nisar MI, Ohkubo T, Oti SO, Pedroza A, Prabhakaran D, Roy N, Sampson U, Seo H, Sepanlou SG, Shibuya K, Shiri R, Shiue I, Singh GM, Singh JA, Skirbekk V, Stapelberg NJ, Sturua L, Sykes BL, Tobias M, Tran BX, Trasande L, Toyoshima H, van de Vijver S, Vasankari TJ, Veerman JL, Velasquez-Melendez G, Vlassov VV, Vollset SE, Vos T, Wang C, Wang X, Weiderpass E, Werdecker A, Wright JL, Yang YC, Yatsuya H, Yoon J, Yoon SJ, Zhao Y, Zhou M, Zhu S, Lopez AD, Murray CJ, Gakidou E. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014;384:766–81.10.1016/S0140-6736(14)60460-8Search in Google Scholar

40. Catalano PM. The impact of gestational diabetes and maternal obesity on the mother and her offspring. J Dev Orig Health Dis 2010;1:208–15.10.1017/S2040174410000115Search in Google Scholar

41. Gibson KS, Waters T, Catalano PM. Factors relating to national trends in decreasing birth weight in term singleton deliveries. Society for Gynecologic Investigation 2011;18(Suppl): 210A (abstract F130).Search in Google Scholar

42. Institute of Medicine. Weight gain during pregnancy: reexamining the guidelines. Washington, DC: National Academy Press, 2009.Search in Google Scholar

43. Catalano PM, Farrell K, Thomas A, Huston-Presley L, Mencin P, Hauguel-de Mouzon S, Amini SB. Perinatal risk factors for childhood obesity and metabolic dysregulation. Am J Clin Nutr 2009;90:1303–13.10.3945/ajcn.2008.27416Search in Google Scholar

44. Kopp-Hoolihan LE, van Loan MD. Fat mass deposition during pregnancy using a four-component model. J Appl Physiol 1992;87:196–202.10.1152/jappl.1999.87.1.196Search in Google Scholar

45. Ehrenberg HM, Huston-Presley L, Catalano PM. The influence of obesity and gestational diabetes mellitus on accretion and the distribution of adipose tissue in pregnancy. Am J Obstet Gynecol 2003;189:944–8.10.1067/S0002-9378(03)00761-0Search in Google Scholar

46. Ghio A, Bertolotto A, Resi V, Volpe L, Di Cianni G. Triglyceride metabolism in pregnancy. Adv Clin Chem 2011;55:133–53.10.1016/B978-0-12-387042-1.00007-1Search in Google Scholar

47. Ramsay JE, Ferrell WR, Crawford L, Wallace AM, Greer IA, Sattar N. Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. J Clin Endocrinol Metab 2002;87:4231–7.10.1210/jc.2002-020311Search in Google Scholar

48. Ranheim T, Haugen F, Staff AC, Braekke K, Harsem NK, Drevon CA. Adiponectin is reduced in gestational diabetes mellitus in normal weight women. Acta Obstet Gynecol Scand 2004;83:341–7.10.1111/j.0001-6349.2004.00413.xSearch in Google Scholar

49. Mazaki-Tovi S, Romero R, Vaisbuch E, Erez O, Mittal P, Chaiworapongsa T, Kim SK, Gotsch F, Lamont R, Ogge G, Pacora P, Goncalves L, Kim CJ, Gomez R, Espinoza J, Hassan SS, Kusanovic JP. Maternal serum adiponectin multimers in gestational diabetes. J Perinat Med 2009;37:637–50.10.1515/JPM.2009.101Search in Google Scholar

50. Lihn AS, Bruun JM, He G, Pedersen SB, Jensen PF, Richelsen B. Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Mol Cell Endocrinol 2004;219:9–15.10.1016/j.mce.2004.03.002Search in Google Scholar

51. Misra VK, Trudeau S. The influence of overweight and obesity on longitudinal trends in maternal serum leptin levels during pregnancy. Obesity (Silver Spring) 2011;19:416–21.10.1038/oby.2010.172Search in Google Scholar

52. Ozias MK, Li S, Hull HR, Brooks WM, Carlson SE. Relationship of circulating adipokines to body composition in pregnant women. Adipocyte 2014;4:44–9.10.4161/adip.29805Search in Google Scholar

53. Ranganathan S, Maffei M, Kern PA. Adipose tissue OB mRNA expression in humans: discordance with plasma leptin and relationship with adipose TNF-alpha expression. J Lipid Res 1998;39:724–30.10.1016/S0022-2275(20)32561-XSearch in Google Scholar

54. Lönnqvist F, Arner P, Nordfors L, Schalling M. Overexpression of the obese(ob) gene in adipose tissue of human obese subjects. Nat Med 1995;1:950–3.10.1038/nm0995-950Search in Google Scholar PubMed

55. Clapham JC, Smith SA, Moore GB, Hughes MG, Azam H, Scott A, Jung RT. Plasma leptin concentrations and OB gene expression in subcutaneous adipose tissue are not regulated acutely by physiological hyperinsulinaemia in lean and obese humans. Int J Obes Relat Metab Disord 1997;21:178–83.10.1038/sj.ijo.0800384Search in Google Scholar PubMed

56. Blanchette S, Marceau P, Biron S, Brochu G, Tchernof A. Circulating progesterone and obesity in men. Horm Metab Res 2006;38:330–5.10.1055/s-2006-925392Search in Google Scholar

57. Mele J, Muralimanoharan S, Maloyan A, Myatt L. Impaired mitochondrial function in human placenta with increased maternal adiposity. Am J Physiol Endocrinol Metab 2014;307:E419–25.10.1152/ajpendo.00025.2014Search in Google Scholar

58. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW, Shulman GI. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 2003;300:1140–2.10.1126/science.1082889Search in Google Scholar

59. Kelley DE, He J, Menshikova EV, Ritov VB. Dysfunction of mitochondria in human skeletal muscle in type 2. Diabetes 2002;51:2944–50.10.2337/diabetes.51.10.2944Search in Google Scholar

60. Bournat JC, Brown CW. Mitochondrial dysfunction in obesity. Curr Opin Endocrinol Diabetes Obes 2010;17:446–52.10.1097/MED.0b013e32833c3026Search in Google Scholar

61. Catalano PM, Huston L, Amini SB, Kalhan SC. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol 1999;180:903–16.10.1016/S0002-9378(99)70662-9Search in Google Scholar

62. Catalano PM, Ehrenberg HM. The short-and long-term implications of maternal and obesity on the mother and her offspring. BJOG 2006;113:1126–33.10.1111/j.1471-0528.2006.00989.xSearch in Google Scholar PubMed

63. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–9.10.1007/BF00280883Search in Google Scholar PubMed

64. Okereke NC, Huston-Presley L, Amini SB, Kalhan S, Catalano PM. Longitudinal changes in energy expenditure and body composition in obese women with normal and impaired glucose tolerance. Am J Physiol Endocrinol Metab 2004;287:E472–9.10.1152/ajpendo.00589.2003Search in Google Scholar PubMed

65. Sivan E, Homko CJ, Chen X, Reece EA, Boden G. Effect of insulin on fat metabolism during and after normal pregnancy. Diabetes 1999;48:834–8.10.2337/diabetes.48.4.834Search in Google Scholar PubMed

66. Eckel RH. Insulin resistance: an adaptation for weight maintenance. Lancet 1992;340:1452–3.10.1016/0140-6736(92)92633-QSearch in Google Scholar

67. Schonfeld P, Wojtczak L. Fatty acids as modulators of the cellular production of reactive oxygen ecies. Free Radic Biol Med 2008;45:231–41.10.1016/j.freeradbiomed.2008.04.029Search in Google Scholar PubMed

68. Nakamura MT, Yudell BE, Loor JJ. Regulation of energy metabolism by long-chain fatty acids. Prog Lipid Res 2014;53:124–44.10.1016/j.plipres.2013.12.001Search in Google Scholar PubMed

69. Corkey BE. Banting lecture 2011: hyperinsulinemia: cause or consequence? Diabetes 2012;61:4–13.10.2337/db11-1483Search in Google Scholar PubMed PubMed Central

70. Boden G, Chen X, Rosner J, Barton M. Effects of a 48-h fat infusion on insulin secretion and glucose utilization. Diabetes 1995;44:1239–42.10.2337/diab.44.10.1239Search in Google Scholar PubMed

71. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003;112:1821–30.10.1172/JCI200319451Search in Google Scholar

72. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993;259:87–91.10.1126/science.7678183Search in Google Scholar PubMed

73. Challier JC, Basu S, Bintein T, Minium J, Hotmire K, Catalano PM, Hauguel-de Mouzon S. Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta 2008;29:274–81.10.1016/j.placenta.2007.12.010Search in Google Scholar PubMed PubMed Central

74. Basu S, Haghiac M, Surace P, Challier JC, Guerre-Millo M, Singh K, Waters T, Minium J, Presley L, Catalano PM, Hauguel-de Mouzon S. Pre-gravid obesity associates with increased maternal endotoxemia and metabolic inflammation. Obesity (Silver Spring) 2011;19:476–82.10.1038/oby.2010.215Search in Google Scholar PubMed PubMed Central

75. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006;444:860–7.10.1038/nature05485Search in Google Scholar PubMed

76. Arner P. Resistin: yet another adipokine tells us that men are not mice. Diabetologia 2005;48:2203–5.10.1007/s00125-005-1956-3Search in Google Scholar PubMed